| __timestamp | Bausch Health Companies Inc. | CRISPR Therapeutics AG |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 5114000 |
| Thursday, January 1, 2015 | 2682700000 | 13403000 |
| Friday, January 1, 2016 | 2810000000 | 31056000 |
| Sunday, January 1, 2017 | 2582000000 | 35845000 |
| Monday, January 1, 2018 | 2473000000 | 48294000 |
| Tuesday, January 1, 2019 | 2554000000 | 63488000 |
| Wednesday, January 1, 2020 | 2367000000 | 88208000 |
| Friday, January 1, 2021 | 2624000000 | 102802000 |
| Saturday, January 1, 2022 | 2625000000 | 102464000 |
| Sunday, January 1, 2023 | 2917000000 | 76162000 |
| Monday, January 1, 2024 | 72977000 |
Cracking the code
In the ever-evolving landscape of the healthcare and biotechnology sectors, understanding spending patterns is crucial. Bausch Health Companies Inc. and CRISPR Therapeutics AG present a fascinating study in contrasts. Over the past decade, Bausch Health's Selling, General, and Administrative (SG&A) expenses have consistently dwarfed those of CRISPR Therapeutics, averaging around 2.6 billion annually. In contrast, CRISPR's SG&A expenses have grown from a modest 5 million in 2014 to over 100 million in 2021, reflecting a staggering 1,900% increase.
While Bausch Health's expenses have shown a steady trend, peaking at nearly 2.9 billion in 2023, CRISPR's rapid growth in SG&A spending highlights its aggressive expansion strategy. This divergence underscores the different stages and strategies of these companies, offering valuable insights for investors and industry analysts alike.
Biogen Inc. or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
Dr. Reddy's Laboratories Limited vs CRISPR Therapeutics AG: SG&A Expense Trends
Bio-Techne Corporation vs CRISPR Therapeutics AG: SG&A Expense Trends
Comparing SG&A Expenses: Catalent, Inc. vs Bausch Health Companies Inc. Trends and Insights
Alkermes plc vs Bausch Health Companies Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or CRISPR Therapeutics AG
Alpine Immune Sciences, Inc. or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and CRISPR Therapeutics AG
Who Optimizes SG&A Costs Better? CRISPR Therapeutics AG or Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: CRISPR Therapeutics AG vs Wave Life Sciences Ltd. Trends and Insights
Operational Costs Compared: SG&A Analysis of CRISPR Therapeutics AG and Galapagos NV
Operational Costs Compared: SG&A Analysis of Bausch Health Companies Inc. and Taro Pharmaceutical Industries Ltd.